Recent advances in clinical studies and the evolving role of subtyping for patients with diffuse large B-cell lymphoma

Grzegorz S Nowakowski, Umberto Vitolo

Research output: Contribution to journalReview article

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)859-862
Number of pages4
JournalFuture Oncology
Volume13
Issue number10
DOIs
StatePublished - Apr 1 2017

Fingerprint

Lymphoma, Large B-Cell, Diffuse
Drug Therapy
Clinical Studies

Keywords

  • chemotherapy
  • hematologic/lymphoma
  • molecular oncology

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Recent advances in clinical studies and the evolving role of subtyping for patients with diffuse large B-cell lymphoma. / Nowakowski, Grzegorz S; Vitolo, Umberto.

In: Future Oncology, Vol. 13, No. 10, 01.04.2017, p. 859-862.

Research output: Contribution to journalReview article

@article{7abf55b4963b47078dd645f7e36fdec1,
title = "Recent advances in clinical studies and the evolving role of subtyping for patients with diffuse large B-cell lymphoma",
keywords = "chemotherapy, hematologic/lymphoma, molecular oncology",
author = "Nowakowski, {Grzegorz S} and Umberto Vitolo",
year = "2017",
month = "4",
day = "1",
doi = "10.2217/fon-2016-0567",
language = "English (US)",
volume = "13",
pages = "859--862",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "10",

}

TY - JOUR

T1 - Recent advances in clinical studies and the evolving role of subtyping for patients with diffuse large B-cell lymphoma

AU - Nowakowski, Grzegorz S

AU - Vitolo, Umberto

PY - 2017/4/1

Y1 - 2017/4/1

KW - chemotherapy

KW - hematologic/lymphoma

KW - molecular oncology

UR - http://www.scopus.com/inward/record.url?scp=85014862105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014862105&partnerID=8YFLogxK

U2 - 10.2217/fon-2016-0567

DO - 10.2217/fon-2016-0567

M3 - Review article

C2 - 28183193

AN - SCOPUS:85014862105

VL - 13

SP - 859

EP - 862

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 10

ER -